Add To Watchlist
Share URL
About The Company
Description
CollPlant Biotechnologies Ltd.
Read More
Overview
Value
6
Growth
42
Health
65
Management
61
Analyst Opinion
60
Total
42
All Scores Out Of 100
Best Features
- Has a low level of debt
- Low risk of bankruptcy
- Has strong financial health
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings have declined recently
- Income is not covering expenditure and investment
- There is a history of diluting shareholders
- No margin of safety at their current market price
- Disliked by Twitter users 0
Latest News

CollPlant Biotechnologies Ltd. (CLGN) Q4 2022 Earnings Call Transcript
Seeking Alpha | 18:28 Wed 29 Mar 2023
Read More →

CollPlant: Expanding End-Market Opportunities
Seeking Alpha | 11:31 Sun 12 Feb 2023
Read More →

CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy
PRNewsWire | 13:00 Mon 19 Sept 2022
Read More →

New Strong Sell Stocks for April 22nd
Zacks Investment Research | 16:32 Fri 22 Apr 2022
Read More →
Market Peers
CLGN
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-58.43%
Revenue Growth (5 Year Average)
24.86%
Ratings Consensus
Neutral
Share Buybacks
-44.75%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
6
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 3 USD ✘
Current Price: 7.2 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-18.39%
PE/Earnings Growth
N/A
Price/Book
2.25x
Growth
Growth Score
42
- ✔ 5 Year Average Revenue growth of 24.86% is higher than the market average (10.97%)
- ✘ Revenue growth has slowed this year
- ✘ 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of N/A is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
24.86%
Earnings Growth
N/A
Cashflow Growth
N/A
Health
Health Score
65
Altman Z Score
7.53
Piostroski Score
3.00
Debt/Equity
0.08x
Current Assets/Liabilities
14.96x
Free Cashflow/Total Debt
0.25x
Debt/Capital
0.08x
Management
Management Score
61
Average Buybacks/Dilution
-44.75%
Recent Buybacks/Dilution
12.21%
5 Year Price Volitility
32.80%
Return On Assets
0.44%
Return On Capital Employed
3.62%
Return On Equity
0.50%
Return On Free Cashflow
-4.50%
Return On Investments
N/A
Analysts
Analyst Opinion
60
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
CollPlant Biotechnologies Ltd.
Currency
USD
Beta
0.689222
Vol Avg
30642
Ceo
Mr. Eran Rotem CPA
Cik
0001631487
Cusip
19516R107
Exchange
NASDAQ Global Market
Full Time Employees
66
Industry
Biotechnology
Sector
Healthcare
Ipo Date
1993-09-01
Address
4 Oppenheimer Street, P.O. Box 4132
City
Rehovot
State
Country
IL
Zip
7670104
Phone
972732325600
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
20
Twitter Sentiment
N/A
Stocktwits Sentiment
39.00